Summary: Pfizer Inc. receives FDA approval for the supplemental BLA for ADCETRIS in combination therapy for the treatment of relapsed or refractory large B-cell lymphoma, showing significant improvement in overall survival based on Phase 3 study. The therapy provides a new option for patients who have failed two prior lines of therapy.
Full articleSummary: The US EEOC filed a lawsuit against Smithfield Foods Inc., alleging age discrimination against a senior sales employee who was fired at the age of 59. Smithfield claimed termination was part of a reduction-in-force, but most terminated employees were 55 or older. The case will be heard in the US District Court for the Northern District of Georgia.
Full articleSummary: Envestnet and Salesforce have partnered to offer advisors a more streamlined platform on the cloud for financial planning, aiming to help advisors operate across multiple systems and applications on one platform for better portfolio monitoring and client engagement.
Full articleSummary: The US trucking market continues to struggle as shown by US Bank’s Freight Payment Index for the first quarter, which revealed declines in shipment count and freight spending. Winter storms, decreased demand after peak season, and other factors contributed to the challenges faced by the trucking sector. Despite some economic indicators pointing to improvement, analysts predict ongoing difficulties due to excess capacity in the market.
Full articleSummary: Gilead Sciences, Inc. receives FDA approval for updated label on Biktarvy for treating pregnant people with HIV-1, reinforcing safety and efficacy profile.
Full articleSummary: Medtronic is launching the Inceptiv SCS, a new spinal cord stimulation system that offers real-time adjustments to stimulation based on the body's response. It provides full-body MRI access without restrictions and is designed for patient comfort, offering multiple types of waveforms and a mobile application for therapy guidance. The system has already been approved for sale in Europe and Japan, and will soon launch in the U.S.
Full articleSummary: Pfizer Inc. has announced FDA approval for BEQVEZ for the treatment of adults with moderate to severe hemophilia B, offering a one-time gene therapy as an alternative to regular FIX infusions.
Full article